Cargando…
Molecular Targeted Therapies in Metastatic Prostate Cancer: Recent Advances and Future Challenges
SIMPLE SUMMARY: Recent studies have highlighted the importance of molecular targeted therapies in metastatic castration-resistant prostate cancer. These therapies, which aim to block specific molecules and related pathways in cancer cells, or in cells present in their microenvironment, and inhibit t...
Autores principales: | Sorrentino, Carlo, Di Carlo, Emma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251915/ https://www.ncbi.nlm.nih.gov/pubmed/37296848 http://dx.doi.org/10.3390/cancers15112885 |
Ejemplares similares
-
Targeting BRAF-Mutant Biliary Tract Cancer: Recent Advances and
Future Challenges
por: Rizzo, Alessandro, et al.
Publicado: (2020) -
Heterocyclic Molecular Targeted Drugs and Nanomedicines for Cancer: Recent Advances and Challenges
por: Liu, Junxia, et al.
Publicado: (2023) -
PSMA-Targeting Radiopharmaceuticals for Prostate Cancer Therapy: Recent Developments and Future Perspectives
por: El Fakiri, Mohamed, et al.
Publicado: (2021) -
Recent and Future Strategies to Overcome Resistance to Targeted Therapies and Immunotherapies in Metastatic Colorectal Cancer
por: Dazio, Giulia, et al.
Publicado: (2022) -
Recent advances and future challenges of tumor vaccination therapy for recurrent glioblastoma
por: Zhao, Binghao, et al.
Publicado: (2023)